Dawaa Reference

Clinical reference

Simple (Euthyroid) Goitre

Treatment options, dosing, cautions and Egyptian brands from the shipped Dawaa Reference card.

Evidence status

Checked against the sources named below

Sources2 sources

NICE CKS: Thyroid disease 2023 · 2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management (PMC10448590)

Verified against1 document
  • 2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management (PMC10448590)

Verified date2026-08

Presentation reference

Is it this?

Reference only, to read alongside your own examination.

Symptoms — what the patient reports (3)

  • Difficulty swallowing, breathlessness, or a hoarse voice can occur when the enlarged gland presses on nearby nerves [breathlessness · difficulty swallowing · hoarseness]
  • A large gland pressing on neck veins can cause facial fullness and discomfort
  • Pain is uncommon but can be sudden and severe if a nodule bleeds internally [bleeding]

Signs — what you find (3)

  • A central neck mass, smooth or lumpy, that rises and falls with swallowing is the typical finding [neck lump]
  • Palpable lymph nodes in the neck alongside the goiter should raise concern for cancer and prompt further workup [goitre]
  • Raising the arms overhead can push the goiter into the chest inlet and trigger noisy breathing, breathlessness, or visibly distended neck veins [breathlessness · goitre · raised JVP]

Tests (6)

  • Thyroid hormone blood tests establish whether the gland is overactive, underactive, or normally functioning
  • On ultrasound, a dark nodule, tiny calcium flecks, rich blood flow, or a solid component within a complex nodule raise suspicion
  • A needle sample of the nodule under ultrasound guidance is advised when suspicious features are found
  • A chest X-ray helps assess whether the goiter extends into the chest or is pushing the windpipe out of place
  • CT or MRI can map how the goiter relates to the airway and whether it extends behind the trachea or into the chest
  • Checking vocal cord movement by laryngoscopy before surgery is important, especially if the voice is hoarse

If not this — what else fits (3)

  • A large, fixed, hard swelling that does not move should raise concern for the most aggressive thyroid cancer subtype
  • Papillary, follicular, and medullary thyroid cancer and thyroid lymphoma must be excluded before calling a goiter benign
  • Inflammatory thyroid conditions such as Hashimoto, De Quervain, and Riedel thyroiditis need to be told apart from a simple goiter

SourceStatPearls "Nontoxic Goiter" - disease-level clinical article

Presentation findings are traced to the source above.

1

CLINICAL MONITORING & WATCHFUL WAITING (PRIMARY CARE)

1st line
Adult dose and duration

Confirm euthyroid with TSH and free T4, and get a baseline ultrasound. Then scan by risk, not by calendar: a benign or low-risk nodule (EU-TIRADS 2-3) under 10 mm needs no further imaging at all, and over 10 mm is re-evaluated in 3-5 years. Intermediate risk (EU-TIRADS 4) is re-evaluated within 1 year, high risk (EU-TIRADS 5) every 6-12 months. No drug treatment is needed for an asymptomatic euthyroid goitre - lifelong, at an interval set by the ultrasound risk category

Paediatric dose

Pediatric goitre requires pediatric endocrinology evaluation to rule out juvenile autoimmune thyroiditis or iodine deficiency.

Dose source

2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management (PMC10448590)

Why

Most simple euthyroid goitres are benign, asymptomatic, and remain stable without active drug treatment; routine TSH suppression with levothyroxine is discouraged due to long-term cardiac and bone risks.

Cautions
  • A blanket 12-24 month scan is wrong in both directions - it over-scans a benign nodule that needs nothing for 3-5 years, and under-scans a high-risk one that needs 6-12 months.
  • Screen for compressive symptoms (dysphagia, dyspnea, hoarseness, stridor) which require urgent ENT and endocrinology referral for surgical evaluation.
  • Perform baseline thyroid ultrasound to evaluate gland volume and rule out suspicious nodules requiring fine-needle aspiration biopsy (FNAB).
  • Re-check serum TSH annually or if clinical symptoms of thyroid dysfunction develop.
  • Do not give levothyroxine to shrink it. The guideline is explicit: thyroid hormone treatment is not indicated in euthyroid people with nodular thyroid disease. It does not reliably shrink the nodule, and suppressing TSH carries its own morbidity and mortality.

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.